Thomas Renz, DO
Orthopaedic Surgery · Lancaster, PANPI 1548256597
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 90.8% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $1,294, 7.2 times the $179 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in PA, where the typical reported total is $3,243.
Across 17 payments — averaging $115.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2K
- Johnson & Johnson$146
- Smith+Nephew$26
- Heraeus Medical, LLC.$10
Across 15 payments — averaging $2861.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$43K
What the payments were for
- Travel & lodging$64833%
- Food & beverage$86244%
- Education$45523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 13 | $1,784 |
| Johnson & Johnson(2 entities) | 2 | $146 |
| Smith+Nephew | 1 | $26 |
| Heraeus Medical, LLC. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXFORD PARTIAL KNEE$435
- Oxford$193
- ROSA$152
- ATTUNE$119
- CORAIL$119
How this compares
$1,965 in reported general payments places this provider in the 40th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $3,509 |
| Methylprednisolone | 62 | $335 |
| Celecoxib | 17 | $280 |
| Cefadroxil | 18 | $251 |
| Gabapentin | 40 | $197 |
| Duloxetine Hcl | 12 | $142 |
| Meloxicam | 41 | $36 |
| Amoxicillin | 41 | $33 |
| Tramadol Hcl | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lancaster
- Michael BercikLancaster$214K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.